Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
279
Frequently Asked Questions
What is Market Cap of Pulmonx Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pulmonx Corp market cap is $238.33M.
What is the 52-week high for Pulmonx Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pulmonx Corp 52 week high is $14.84 as of June 25, 2024.
What is the 52-week low for Pulmonx Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pulmonx Corp 52 week low is $5.67 as of June 25, 2024.
What is Pulmonx Corp stock price today?
Pulmonx Corp stock price today is $6.14.
What was Pulmonx Corp stock price yesterday?
Pulmonx Corp stock price yesterday was $6.22.
What is the PE ratio of Pulmonx Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pulmonx Corp’s P/E ratio is -4.00.
What is the Price-to-Book ratio of Pulmonx Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pulmonx Corp P/B ratio is 2.1567.
What is Pulmonx Corp's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Pulmonx Corp's EBITDA is -4.90.
What is the 50-day moving average of Pulmonx Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pulmonx Corp 50-day moving average is $7.68.